A Real-Life, International, Observational Study Demonstrating The Efficacy Of A Cosmetic Emulsion In The Supportive Care Of Mild-To-Moderate Facial Acne

References

• Hollestein LM, Nijsten T. An insight into the global burden of skin diseases. J Invest Dermatol. 2014;134(6):1499–1501. doi:10.1038/jid.2013.51324825057
   PubMed Web of Science ®Google Scholar
• Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009;129(9):2136–2141. doi:10.1038/jid.2009.4719282841
   PubMed Web of Science ®Google Scholar
• Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58(1):56–59. doi:10.1016/j.jaad.2007.06.04517945383
   PubMed Web of Science ®Google Scholar
• Holzmann R, Shakery K. Postadolescent acne in females. Skin Pharmacol Physiol. 2014;27(Suppl 1):3–8. doi:10.1159/00035488724280643
   PubMed Web of Science ®Google Scholar
• Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131(2):363–370. doi:10.1038/jid.2010.26420844551
   PubMed Web of Science ®Google Scholar
• Misery L. Consequences of psychological distress in adolescents with acne. J Invest Dermatol. 2011;131(2):290–292. doi:10.1038/jid.2010.37521228811
   PubMed Web of Science ®Google Scholar
• Hazarika N, Archana M. The psychosocial impact of acne vulgaris. Indian J Dermatol. 2016;61(5):515–520. doi:10.4103/0019-5154.19010227688440
   PubMed Web of Science ®Google Scholar
• Zaraa I, Belghith I, Ben Alaya N, Trojjet S, Mokni M, Ben Osman A. Severity of acne and its impact on quality of life. Skinmed. 2013;11(3):148–153.23930353
   PubMedGoogle Scholar
• Vilar GN, Santos LA, Sobral Filho JF. Quality of life, self-esteem and psychosocial factors in adolescents with acne vulgaris. An Bras Dermatol. 2015;90(5):622–629. doi:10.1590/abd1806-4841.20153372626560206
   PubMed Web of Science ®Google Scholar
• Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011;3(1):41–49. doi:10.4161/derm.3.1.1390021519409
   PubMedGoogle Scholar
• Jahns AC, Eilers H, Ganceviciene R, Alexeyev OA. Propionibacterium species and follicular keratinocyte activation in acneic and normal skin. Br J Dermatol. 2015;172(4):981–987. doi:10.1111/bjd.1343625279837
   PubMed Web of Science ®Google Scholar
• Beylot C, Auffret N, Poli F, et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014;28(3):271–278. doi:10.1111/jdv.1222423905540
   PubMed Web of Science ®Google Scholar
• Contassot E, French LE. New insights into acne pathogenesis: propionibacterium acnes activates the inflammasome. J Invest Dermatol. 2014;134(2):310–313. doi:10.1038/jid.2013.50524424454
   PubMed Web of Science ®Google Scholar
• Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211(3):193–198. doi:10.1159/00008701116205063
   PubMed Web of Science ®Google Scholar
• Taylor M, Gonzalez M, Porter R. Pathways to inflammation: acne pathophysiology. Eur J Dermatol. 2011;21(3):323–333. doi:10.1684/ejd.2011.135721609898
   PubMed Web of Science ®Google Scholar
• Suh DH, Kwon HH. What’s new in the physiopathology of acne? Br J Dermatol. 2015;172(Suppl 1):13–19. doi:10.1111/bjd.2015.172.issue-S1
   PubMed Web of Science ®Google Scholar
• Kircik LH. Advances in the understanding of the pathogenesis of inflammatory acne. J Drugs Dermatol. 2016;15(1 Suppl 1):s7–s10.26741394
   PubMedGoogle Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e933. doi:10.1016/j.jaad.2015.12.03726897386
   PubMed Web of Science ®Google Scholar
• Humphrey S. Antibiotic resistance in acne treatment. Skin Therapy Lett. 2012;17(9):1–3.
   PubMedGoogle Scholar
• Moradi Tuchayi S, Alexander TM, Nadkarni A, Feldman SR. Interventions to increase adherence to acne treatment. Patient Prefer Adherence. 2016;10:2091–2096. doi:10.2147/PPA.S11743727784999
   PubMed Web of Science ®Google Scholar
• Guerrero D. [Dermo-cosmetic approach to acne by the dermatologist]. Ann Dermatol Venereol. 2010;137(Suppl 2):S76–S80. doi:10.1016/S0151-9638(10)70032-621095502
   PubMed Web of Science ®Google Scholar
• Araviiskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30(6):926–935. doi:10.1111/jdv.1357926916232
   PubMed Web of Science ®Google Scholar
• Dall’oglio F, Tedeschi A, Fabbrocini G, Veraldi S, Picardo M, Micali G. Cosmetics for acne: indications and recommendations for an evidence-based approach. G Ital Dermatol Venereol. 2015;150(1):1–11.25315288
   PubMed Web of Science ®Google Scholar
• Goh CL, Noppakun N, Micali G, et al. Meeting the challenges of acne treatment in Asian patients: a review of the role of dermocosmetics as adjunctive therapy. J Cutan Aesthet Surg. 2016;9(2):85–92. doi:10.4103/0974-2077.18404327398008
   PubMedGoogle Scholar
• Bartenjev I, Oremovic L, Rogl Butina M, et al. Topical effectiveness of a cosmetic skincare treatment for acne-prone skin: a clinical study. Acta Dermatovenerol Alp Pannonica Adriat. 2011;20(2):55–62.21993702
   PubMedGoogle Scholar
• Trompezinski S, Weber S, Cadars B, et al. Assessment of a new biological complex efficacy on dysseborrhea, inflammation, and Propionibacterium acnes proliferation. Clin Cosmet Investig Dermatol. 2016;9:233–239. doi:10.2147/CCID.S110655
   PubMed Web of Science ®Google Scholar
• Saint-Jean M, Khammari A, Seite S, Moyal D, Dreno B. Characteristics of premenstrual acne flare-up and benefits of a dermocosmetic treatment: a double-blind randomised trial. Eur J Dermatol. 2017;27(2):144–149.
   Web of Science ®Google Scholar
• Polakova K, Fauger A, Sayag M, Jourdan E. A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial. Clin Cosmet Investig Dermatol. 2015;8:187–191. doi:10.2147/CCID.S81691
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Center for Drug Evaluation and Research. Guidance for Industry. Acne Vulgaris: Developing Drugs for treatment. In: Services. DoHaH; 9 2005.
   Google Scholar
• Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(Suppl 1):1–29. doi:10.1111/j.1468-3083.2011.04374.x
   PubMed Web of Science ®Google Scholar
• Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17(1):1–3. doi:10.1111/j.1365-2230.1992.tb02521.x1424249
   PubMed Web of Science ®Google Scholar
• Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474–485. doi:10.1111/bjd.1214923210645
   PubMed Web of Science ®Google Scholar
• Dreno B, Jean-Decoster C, Georgescu V. Profile of patients with mild-to-moderate acne in Europe: a survey. Eur J Dermatol. 2016;26(2):177–184. doi:10.1684/ejd.2015.272227032481
   PubMed Web of Science ®Google Scholar
• Wei B, Pang Y, Zhu H, et al. The epidemiology of adolescent acne in North East China. J Eur Acad Dermatol Venereol. 2010;24(8):953–957. doi:10.1111/j.1468-3083.2010.03590.x20337811
   PubMed Web of Science ®Google Scholar
• Kosmadaki M, Katsambas A. Topical treatments for acne. Clin Dermatol. 2017;35(2):173–178. doi:10.1016/j.clindermatol.2016.10.01028274355
   PubMed Web of Science ®Google Scholar
• Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:709152. doi:10.1155/2014/70915225120566
   PubMedGoogle Scholar